The INCI of Tea Tree Essential Oil: A Scientific Profile

Written by Mark Williams

The INCI name for tea tree essential oil is Melaleuca Alternifolia (Tea Tree) Leaf Oil, CAS No. 68647-73-4. This essential oil is steam-distilled from the leaves of the Australian native plant Melaleuca alternifolia and functions in cosmetics as an antimicrobial, antioxidant, skin-conditioning, and fragrance ingredient. Its chemical composition is governed by the ISO 4730:2017 standard, which requires a minimum terpinen-4-ol content of 30% and caps 1,8-cineole at 15%.

Cosmetic chemists and ingredient-conscious consumers alike often encounter Melaleuca Alternifolia Leaf Oil on product labels without understanding what governs its quality, safety, or performance. Unlike synthetic ingredients with fixed molecular structures, tea tree oil is a complex botanical extract whose composition can vary significantly depending on sourcing, distillation method, and storage conditions. This variability makes the INCI designation only the starting point for evaluating a given batch of oil.

This article examines the scientific basis of the INCI classification for tea tree essential oil, its chemical composition, its documented mechanisms of action, and the regulatory considerations currently shaping its use in cosmetic formulations.

What Does INCI Mean and Why Does It Matter for Tea Tree Oil?

INCI, or International Nomenclature of Cosmetic Ingredients, is a standardized naming system used to identify ingredients on cosmetic product labels across most regulatory jurisdictions, including the European Union and the United States. For tea tree essential oil, the INCI designation is Melaleuca Alternifolia (Tea Tree) Leaf Oil, sometimes rendered without the parenthetical common name as Melaleuca Alternifolia Leaf Oil.

This nomenclature identifies both the botanical source (genus and species) and the plant part from which the oil is derived (leaf). The CAS Registry Number 68647-73-4 provides an additional, internationally recognized identifier used in safety data sheets, regulatory submissions, and toxicological databases. Formulators and regulators rely on this dual identification system to track the ingredient across supply chains and scientific literature, since common names like “tea tree oil” can be applied loosely to unrelated botanical extracts.

Botanical Origin and Extraction of Melaleuca Alternifolia Leaf Oil

Melaleuca alternifolia is a shrub native to the coastal regions of New South Wales, Australia. Indigenous Australian communities historically used crushed leaves from this plant to treat wounds, bruises, and insect bites, and the oil later gained wider recognition when it was included in military first-aid kits during the Second World War.

Commercial production of tea tree essential oil relies on steam distillation of the plant’s leaves and terminal branchlets. This process separates the volatile aromatic compounds from the plant matrix using steam heat, yielding a pale yellow to nearly colorless oil with a characteristic camphoraceous odor. The efficiency and selectivity of steam distillation directly influence the final chemical profile of the oil, which is why standardized extraction protocols are important for consistency across commercial batches.

What Is the Chemical Composition of Tea Tree Essential Oil According to ISO 4730?

Tea tree essential oil is not a single chemical entity but a complex mixture of more than 100 terpene compounds. To ensure consistency and quality across commercial sources, the International Organization for Standardization established ISO 4730:2017, titled “Essential oil of Melaleuca, terpinen-4-ol type (Tea Tree oil).” This standard defines compositional limits for the oil’s principal constituents and is the reference point cited by regulatory bodies, including the EU Scientific Committee on Consumer Safety (SCCS), when assessing the oil’s safety and identity.

Terpinen-4-ol: The Principal Bioactive Constituent

Terpinen-4-ol is the primary active constituent of tea tree oil and the compound most closely associated with its antimicrobial and anti-inflammatory activity. ISO 4730:2017 requires a minimum terpinen-4-ol concentration of 30%, though analytical studies of commercial samples have reported concentrations as high as 41.6%. Research indicates that terpinen-4-ol, when isolated and tested alone, can produce antimicrobial effects comparable to or exceeding those of the whole oil, underscoring its central role in the oil’s biological activity.

1,8-Cineole: The Component That Sets the Limits

1,8-cineole (also called eucalyptol) is present in tea tree oil but is capped at a maximum of 15% under ISO 4730:2017. This ceiling exists because 1,8-cineole is the constituent most strongly associated with skin irritation. An oil with a low terpinen-4-ol content and a correspondingly high cineole content is therefore considered both less therapeutically active and less well tolerated on skin. One analysis of tea tree oil samples found an average of approximately 27.7% 1,8-cineole alongside 33.0% terpinen-4-ol, illustrating how natural variability can approach regulatory limits.

Secondary Terpene Constituents

Beyond terpinen-4-ol and 1,8-cineole, tea tree oil contains a range of secondary terpenes, including gamma-terpinene, alpha-terpinene, alpha-terpineol, terpinolene, and various pinenes. While present in smaller quantities, these compounds contribute to the oil’s overall aromatic profile and may play supporting roles in its antimicrobial mechanism. Research examining the antibacterial effects of tea tree oil has identified terpinen-4-ol, 1,8-cineole, and alpha-terpinene as the three constituents most critical to its activity against bacterial pathogens.

What Functions Does Melaleuca Alternifolia Leaf Oil Serve in Cosmetic Formulations?

Within cosmetic chemistry, Melaleuca Alternifolia (Tea Tree) Leaf Oil is classified according to four principal functions: antioxidant, skin conditioning, antimicrobial, and fragrance. This multifunctionality explains its widespread inclusion in formulations targeting blemish-prone and oily skin, including cleansers, shampoos, and spot treatments, as well as its use as a fragrance component in household cleaning products.

The antimicrobial function is the most extensively documented and forms the scientific basis for the oil’s popularity in skincare formulations aimed at Cutibacterium acnes (formerly Propionibacterium acnes), the bacterium implicated in acne pathogenesis. The skin-conditioning classification reflects observed effects on skin surface appearance, while the antioxidant designation relates to the oil’s capacity to neutralize reactive oxygen species in vitro.

What Does the Scientific Literature Say About the Antimicrobial Activity of Terpinen-4-ol?

Multiple in vitro studies have demonstrated that tea tree oil, and terpinen-4-ol specifically, disrupts microbial cell membranes, leading to leakage of cellular contents and loss of membrane integrity in bacteria and fungi. This mechanism differs from that of many synthetic antimicrobials and may explain why resistance development has been less commonly reported.

Clinical evidence supports these laboratory findings. A randomized, double-blind, placebo-controlled study of 60 patients with mild to moderate acne, published in the Indian Journal of Dermatology, Venereology and Leprology (Enshaieh et al., 2007), found that a 5% tea tree oil gel produced significant improvements in both total lesion count and acne severity index over a 45-day treatment period, with initial effects observed around day 30. It is worth noting that this concentration substantially exceeds the levels typically found in over-the-counter cosmetic products, and the study population involved mild to moderate presentations rather than severe acne.

A comprehensive review published in Clinical Microbiology Reviews (2006) further consolidated evidence on the oil’s antimicrobial properties and safety profile, establishing it as one of the more well-characterized essential oils in the scientific literature.

Anti-Inflammatory and Antioxidant Mechanisms

Beyond its antimicrobial action, terpinen-4-ol has been shown in vitro to modulate the production of inflammatory mediators, including cytokines and prostaglandins, in human monocytes. This anti-inflammatory activity provides a mechanistic explanation for the oil’s traditional use in soothing redness and discomfort associated with blemished or reactive skin. However, formulators should note that this evidence stems primarily from cell culture studies rather than large-scale clinical trials, and translating in vitro anti-inflammatory activity into predictable clinical outcomes requires caution.

What Is the Regulatory Safety Profile of Tea Tree Oil in Cosmetics?

Tea tree oil’s regulatory status has evolved considerably in recent years, reflecting growing scientific scrutiny of its safety profile at the concentrations used in leave-on and rinse-off cosmetic products.

The 2025 SCCS Draft Opinion (SCCS/1681/25)

Tea tree oil is not currently listed as a restricted substance under EU Cosmetic Regulation (EC) No. 1223/2009. However, in February 2024, the European Chemicals Agency’s Risk Assessment Committee proposed classifying tea tree oil as a Category 1B reproductive toxicant (H360Fd). This classification, if formally adopted into Annex VI of the EU CLP Regulation, would trigger the prohibition provisions of Article 15 of the EU Cosmetics Regulation applicable to CMR (carcinogenic, mutagenic, or reprotoxic) substances, unless specific exemption criteria are met.

In response, the European Commission commissioned the SCCS to evaluate tea tree oil’s safety as an anti-seborrheic and antimicrobial agent. The resulting draft scientific opinion, SCCS/1681/25, released on June 6, 2025, concluded that tea tree oil is safe for use at the following maximum concentrations:

  • Rinse-off shampoo: up to 2.0%
  • Rinse-off shower gel or bubble bath: up to 1.0%
  • Rinse-off facial cleanser: up to 1.0%
  • Leave-on face cream: up to 0.1%

Importantly, these safety thresholds account for the oil’s classification as a Category 1B reproductive toxicant, as well as aggregate exposure from both cosmetic and non-cosmetic sources, with particular attention to vulnerable populations. The opinion applies specifically to tea tree oil meeting the compositional requirements of ISO 4730:2017 and does not extend to aerosol or spray formulations, which could introduce inhalation exposure.

Skin Sensitization and Contact Allergy

Earlier assessments by the EU Scientific Committee on Consumer Products (SCCP), published in 2004 (SCCP/0843/04) and 2008 (SCCP/1155/08), identified tea tree oil as a skin sensitizer capable of causing skin and eye irritation as well as contact allergy. The 2025 SCCS draft opinion reaffirmed this, characterizing tea tree oil as a moderate skin sensitizer. Formulators working with this ingredient should factor sensitization potential into product design, particularly for leave-on applications and products intended for use on compromised or reactive skin barriers.

Stability, Storage, and Oxidation Risk

A frequently overlooked aspect of tea tree oil’s safety profile relates to its chemical stability rather than its baseline composition. Tea tree oil is prone to oxidation when exposed to light, heat, air, or moisture, and the resulting oxidized compounds have been associated with higher rates of skin irritation and sensitization than the fresh oil. Notably, the SCCS draft opinion observed that no stability data were submitted for review, leaving a gap in the current safety assessment regarding the oil’s behavior under real-world storage and use conditions.

To maintain compliance with ISO 4730:2017 specifications throughout a product’s shelf life, tea tree oil should be stored in dark, tightly sealed containers away from heat sources. Formulators incorporating this ingredient into finished products should consider antioxidant stabilization strategies and appropriate packaging to minimize oxidative degradation between manufacture and end use.

Reading the INCI Label: What to Look for When Evaluating Tea Tree Oil in Formulations

The INCI designation Melaleuca Alternifolia (Tea Tree) Leaf Oil identifies the botanical source of an ingredient, but it does not, by itself, guarantee a specific chemical composition, potency, or safety margin. Compliance with ISO 4730:2017—specifically, a terpinen-4-ol content of at least 30% and a 1,8-cineole content no higher than 15%—provides a more meaningful benchmark for evaluating oil quality, since these two constituents directly influence both efficacy and irritation potential.

Given the ongoing regulatory reassessment of tea tree oil’s reproductive toxicity classification and its confirmed status as a moderate skin sensitizer, formulators should approach concentration limits methodically, referencing the maximum use levels outlined in the SCCS’s 2025 draft opinion for the relevant product category. As this opinion remains open for public comment, with a feedback deadline of August 18, 2025, at the time of its release, the regulatory landscape surrounding this ingredient should be monitored closely by anyone formulating with or evaluating products containing Melaleuca Alternifolia Leaf Oil.